Global Bio-chem Technology Group Company Limited Receivables

The latest receivables for GBCMY is $2B as of June 2026. That compares with $100M in the prior-year period — up 1855.8% year over year. Investors often review this figure alongside Global Bio-chem Technology Group Company Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, GBCMY's receivables moved from $100M to $2B — a 1855.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Global Bio-chem Technology Group Company Limited's operating scale or balance-sheet position.

A receivables figure of $2B for GBCMY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GBCMY's receivables ($2B), review year-over-year change from $100M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.